David A. Meh
- Hematology top 2%
- Platelet Disorders and Treatments 7
- Blood Coagulation and Thrombosis Mechanisms 5
- Hemostasis and retained surgical items 1
- Internal Medicine top 5%
-
- Blood properties and coagulation 16
- Urology top 5%
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 1
-
- Botulinum Toxin and Related Neurological Disorders 2
-
- Glycosylation and Glycoproteins Research 1
-
- Rheology and Fluid Dynamics Studies 1
- Co-authors
- Michael W. MosessonKevin R. SiebenlistLaurien H. UlfmanHartmut WeilerMark J. PostEdward M. ConwayJ P DiOrioJeffrey I. Weitz
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Blood (3 papers)
- Partner nations
- United StatesJapanBelgium
In The Last Decade
David A. Meh
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 103
- Hematology 463
- Internal Medicine 67
- Pulmonary and Respiratory Medicine 526
- Urology 91
- Critical Care and Intensive Care Medicine 47
Countries citing papers authored by David A. Meh
This map shows the geographic impact of David A. Meh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Meh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Meh more than expected).
Fields of papers citing papers by David A. Meh
This network shows the impact of papers produced by David A. Meh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Meh. The network helps show where David A. Meh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David A. Meh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 19 | |
| 2 | 2001 | 24 | |
| 3 | 2001 | 471 | |
| 4 | 2001 | 27 | |
| 5 | 2001 | 127 | |
| 6 | Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). | 2000 | 35 |
| 7 | 2000 | 9 | |
| 8 | 1999 | 2 | |
| 9 | 1999 | 30 | |
| 10 | 1998 | 16 | |
| 11 | 1996 | 118 | |
| 12 | 1996 | 108 | |
| 13 | 1995 | 7 | |
| 14 | 1995 | 12 | |
| 15 | Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa. | 1995 | 12 |
| 16 | 1993 | 2 | |
| 17 | The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin. | 1993 | 3 |
| 18 | 1988 | 18 | |
| 19 | 1987 | 2 |
About David A. Meh
David A. Meh is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Blood properties and coagulation (16 papers), Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Glycosylation and Glycoproteins Research (1 paper), Hemostasis and retained surgical items (1 paper), Rheology and Fluid Dynamics Studies (1 paper) and Trauma, Hemostasis, Coagulopathy, Resuscitation (1 paper). The work is most often cited by research in Hematology (463 citations), Internal Medicine (67 citations) and Pulmonary and Respiratory Medicine (526 citations). David A. Meh has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Michael W. Mosesson, Kevin R. Siebenlist, Laurien H. Ulfman, Hartmut Weiler, Mark J. Post, Edward M. Conway, J P DiOrio, Jeffrey I. Weitz, Volkhard Lindner and Brian C. Cooley. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.